New directions in antiarrhythmic drug therapy for atrial fibrillation

Author： Heijman Jordi   Voigt Niels   Dobrev Dobromir  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.9, Iss.1, 2013-01, pp. : 71-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future directions in antiarrhythmic drug therapy for atrial fibrillation

By Musco Simone   Seltzer Jonathan   Kowey Peter R  

Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. : 545-553

Future Medicine

Access to resources Recommend Favorite

Antiarrhythmic Drug Therapy for Atrial Fibrillation: Focus on Atrial Selectivity and Safety

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 7, Iss. 1, 2009-01 ,pp. : 64-75

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Antiarrhythmic Drug Treatment of Atrial Fibrillation

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 8, Iss. 2, 2013-08 ,pp. : 112-126

Bentham Science Publishers

Access to resources Recommend Favorite

The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation

By Wettwer Erich   Christ Torsten   Endig Sebastian   Rozmaritsa Nadiia   Matschke Klaus   Lynch Joseph J.   Pourrier Marc   Gibson John K.   Fedida David   Knaut Michael   Ravens Ursula  

Cardiovascular Research, Vol. 98, Iss. 1, 2013-04 ,pp. : 145-154

Oxford University Press

Access to resources Recommend Favorite

Atrial Fibrillation – Advances in Drug Therapy

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite